Biomdrin
BioMarin develops genetic therapies for rare genetic diseases and common conditions caused by genetic mutations, founded in 1997.
BioMarin was founded in 1997 with a focus on developing drugs for patients with rare genetic disorders and common diseases caused by genetic mutations. The company applies scientific expertise in genetics and molecular biology to develop therapies targeting the underlying genetic causes of diseases. Their patient-centered approach aims to transform the lives of patients through genetic discovery.